MUTYH and colorectal carcinoma: Carriers of biallelic MUTYH variants exhibit a high lifetime risk of CRC, while it is debatable whether patients with a monoallelic mutation have an increased genetic susceptibility to CRC (1.5–2 fold) [11,12].